Evidence map›Paper›PMID 35179616›Full record

SynthesisEuropean journal of clinical pharmacology2022

Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? a systematic review and meta-analysis.

Eslam Mohammed Rabea, Kirellos Said Abbas, Dina M Awad, Nancy H Elgoweini, Amro Ahmed El-Sakka, Nada H Mahmoud, Basel Abdelazeem

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Eslam Mohammed RabeaFaculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID http://orcid.org/0000-0001-8464-3959
Kirellos Said AbbasFaculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID http://orcid.org/0000-0003-0339-9339
Dina M AwadFaculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID http://orcid.org/0000-0002-2126-8386
Nancy H ElgoweiniFaculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID http://orcid.org/0000-0002-4563-4299
Amro Ahmed El-SakkaFaculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID http://orcid.org/0000-0003-2649-8268
Nada H MahmoudFaculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID http://orcid.org/0000-0002-3819-1944
Basel AbdelazeemMcLaren Health Care, Flint, MI, USA. baselelramly@gmail.com.ORCID http://orcid.org/0000-0002-2919-6196
Alexandria University · EGMcLaren Health Care · USSuez Canal University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWarfarin's therapeutic effect is affected by many factors, including diet modifications. The impact of Ramadan fasting on warfarin is controversial. The aim of this systematic review and meta-analysis was to investigate the effect of Ramadan fasting on patients taking warfarin.

methodsA literature search was done in PubMed, WOS, Scopus, and Embase from inception to May 24, 2021. All relevant studies measuring the international normalized ratio (INR), time in therapeutic range (TTR), or the number of patients within therapeutic range before, during, and after Ramadan were assessed by full-text screening for achieving all of the inclusion criteria. We used the Newcastle-Ottawa Scale for quality assessment and RevMan 5.4 software for meta-analysis.

resultsA total of five studies with 446 patients were included in the meta-analysis. The patients served as their own control. Our pooled analyses showed no significant difference during Ramadan compared to pre-Ramadan (MD: 0.08; 95% CI: - 0.00, 0.15; P = 0.06) and post-Ramadan (MD: - 0.00; 95% CI: - 0.14, 0.14; P = 1.00, respectively). There was only a significant increase in the risk ratio of supratherapeutic INR when comparing post-Ramadan vs. pre-Ramadan (RR: 1.69; 95% CI: 1.22, 2.33; P = 0.001). However, there was no significant risk for supratherapeutic INR during Ramadan compared to pre-Ramadan or post-Ramadan; the number of patients within the therapeutic range of INR during Ramadan compared to pre-Ramadan; and TTR during Ramadan, pre-Ramadan, and post-Ramadan.

conclusionRamadan fasting did not affect INR level, TTR, or the number of patients within the therapeutic range before, during, and after Ramadan. However, there was a possibility of achieving a supratherapeutic INR post-Ramadan compared to pre-Ramadan. Therefore, INR monitoring and warfarin dose adjustments accordingly are recommended after Ramadan.

Indexed as

FastingWarfarinAnticoagulantsHumansInternational Normalized RatioAnticoagulantsWarfarinFastingMeta-analysisRamadanSystematic reviewWarfarin

Identifiers

PMID35179616
OpenAlexW4213152608

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.